FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
0 hedge funds and large institutions have $0 invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $185K → $0 (-$185K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$185K |
FURX Hedge Fund Activity: Q1 2016 in Review
0 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q1 2016, worth a combined $0 — down 100% from $185K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FURX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Metropolitan Life Insurance Company (MetLife), exiting entirely with an estimated $185K sold.
- 0 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q1 2016, down from 1 in Q4 2015.
- Funds reported $0 of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2016, down 100% quarter-over-quarter.
- 0 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2016 and 1 closed out, a net change of -1 holder.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2016 was Metropolitan Life Insurance Company (MetLife), an estimated $185K sold.
Based on aggregated 13F filings for Q1 2016.